RDNTHIGH SIGNALFINANCIAL10-K

RDNT experienced a dramatic swing from $2.8M profit to $18.7M loss despite 13% revenue growth, indicating severe operational efficiency deterioration.

The 767% decline in net income while revenue grew 13% suggests major cost inflation or one-time charges that management failed to control effectively. This disconnect between top-line growth and bottom-line performance represents a fundamental operational problem that could signal broader management execution issues or unsustainable business model changes.

Comparing 2026-03-02 vs 2025-03-03View on EDGAR →
FINANCIAL ANALYSIS

RDNT showed strong revenue growth of 13% to $1.6B and improved operating cash flow by 28% to $298.8M, while expanding assets and equity by approximately 14-21%. However, the company swung dramatically from $2.8M net income to an $18.7M loss despite higher revenues, with operating income also declining 41% to $62M. This financial profile suggests significant non-operating charges or cost structure problems that overshadowed otherwise healthy business fundamentals, creating a mixed but concerning outlook for investors.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
-767.8%
$2.8M-$18.7M

Net income declined 767.8% — review whether driven by operations, interest costs, or non-recurring items.

Operating Income
P&L
-40.7%
$104.6M$62.0M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Interest Expense
P&L
-30.2%
$86K$60K

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Operating Cash Flow
Cash Flow
+28.2%
$233.0M$298.8M

Operating cash flow grew 28.2% — strong conversion of earnings to cash, healthy business fundamentals.

Current Liabilities
Balance Sheet
+22.3%
$479.7M$586.8M

Current liabilities rose 22.3% — increased short-term obligations, watch current ratio.

Stockholders Equity
Balance Sheet
+20.8%
$902.3M$1.1B

Equity base grew 20.8% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Total Assets
Balance Sheet
+14.4%
$3.3B$3.8B

Asset base grew 14.4% — expansion through organic growth, acquisitions, or capital deployment.

Revenue
P&L
+13%
$1.4B$1.6B

Revenue growing 13% — solid top-line momentum, watch margins for quality of growth.

Total Liabilities
Balance Sheet
+11.6%
$2.2B$2.4B

Liabilities increased 11.6% — monitor debt-to-equity ratio and interest coverage.

LANGUAGE CHANGES
NEW — 2026-03-02
PRIOR — 2025-03-03
ADDED
As of December 31, 2025, we operated, directly or indirectly through hospital and health system joint ventures, 418 imaging centers located in Arizona, California, Delaware, Florida, Maryland, Virginia, New Jersey, Texas and New York.
Our services include magnetic resonance imaging ("MRI"), computed tomography ("CT"), positron emission tomography ("PET"), nuclear medicine, mammography, ultrasound, diagnostic radiology ("X-ray"), fluoroscopy and other related procedures.
Integral to the imaging center business is our Digital Health operating segment, which sells computerized systems that distribute, display, store and retrieve digital images.
We have also established a Digital Health segment division, that develops and deploys Artificial Intelligence ("AI") suites to enhance radiologist interpretations of, among others, breast, lung and prostate images.
In addition, AI methods can speed up administrative tasks, such as tracking of individuals who need procedures on a regular basis (i.e., mammograms, follow-up exams, etc.) and alerting our staff to contact the patient and schedule appointments.
+7 more — sign up free →
REMOVED
As of December 31, 2024, we operated, directly or indirectly through joint ventures with hospitals, 398 imaging centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, Texas and New York.
Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures.
Integral to the imaging center business is our software arm headed by our eRad, Inc.
subsidiary, which sells computerized systems that distribute, display, store and retrieve digital images.
We have also established an Artificial Intelligence (AI) division, that develops and deploys AI suites to enhance radiologist interpretations of breast, lung and prostate images.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →